SEED INNOVATIONS LIMITED

Board/Management Information • Sep 1, 2023

National Storage Mechanism | Additional information

RNS Number : 0318L

Seed Innovations Limited

01 September 2023

1 September 2023 

SEED Innovations Limited

("SEED" or the "Company")

Appointment of Executive Director

SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies to which, in normal circumstances, they have limited access to, is pleased to announce that it has strengthened its board with the appointment of Mr. Alfredo Pascual as Executive Director, effective 1 September 2023.

Alfredo has held the position of Vice President of Investment Analysis at SEED Innovations since April 2021. In his role at SEED to date, Alfredo has leveraged his connections in the European cannabis industry sourcing new investments and supporting existing portfolio companies in the space. Latterly Alfredo has applied his analytical skills across all sectors of interest to the Company, while also taking an increasingly pivotal role in the general direction and management of the fund.

Ed McDermott, Chief Executive Officer, commented: "I am thrilled to extend a warm welcome to Alfredo to our Board. Beyond his cannabis industry expertise, Alfredo's analysis has proven extremely valuable  in the implementation of our investment strategy. Alfredo is currently a Level III candidate in the CFA Program, adding an extra layer of value to the board and shareholders alike as we remain committed to our investment policy of disruptive growth opportunities."

The information required by Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies in relation to the appointment of Mr. Alfredo Pascual Romero (known as Mr Alfredo Pascual) (aged 36) is as follows:

Current directorships

Avextra AG (Supervisory Board)

Save as disclosed above, there are no further disclosures required to be made in respect of the appointment of Mr. Alfredo Pascual under Schedule 2(g) or Rule 17 of the AIM Rules for Companies.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

*ENDS*

For further information on the Company please visit:  www.seedinnovations.co or contact: 

Ed McDermott  Lance de Jersey	SEED Innovations Ltd	E: info@seedinnovations.co
James Biddle  Roland Cornish	Beaumont Cornish Limited,  Nomad	T: (0)20 7628 3396
Isabella Pierre  Damon Heath	Shard Capital Partners LLP  Broker	T: (0)20 7186 9927
Catherine Leftley  Ana Ribeiro Isabelle Morris	St Brides Partners Ltd,  Financial PR	E: info@stbridespartners.co.uk

Notes 

Seed Innovations Ltd 

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAFLFFATIILVIV